Posts tagged ATT
Adaptive Testing Technologies (ATT) and bioccess™ Sign Agreement to Commercialize the CAT-MH™ Mental Health Adaptive Test in Latin America
Adaptive Testing Technologies (ATT) and bioccess™ Sign Agreement to Commercialize the CAT-MH™ Mental Health Adaptive Test in Latin America

Adaptive Testing Technologies (ATT), a Chicago-based company; and bioccess™, an Orlando-based market access consulting firm dedicated to helping innovative Medtech companies succeed with their market expansion plans in Latin America, announced that they have entered into a partnership agreement to market and commercialize the CAT-MH™ –the only multi-dimensional clinically validated adaptive behavioral health measures in the world –in Latin America.

Read More
Market AccessJulio G. Martinez-ClarkAdaptive Testing Technologies, ATT, CAT-MH, MENTA, SALUD, prueba ansiedad depresión, prueba suicidioComment